Safety and feasibility of 0.6 mg/kg every 4 weeks dosing of axatilimab in patients treated in the AGAVE-201 study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Nosha Farhadfar, Maria Sola Soto, Saurabh Chhabra, Valkal Bhatt, Emily Andersen, Zhenyi Xue, Zachariah Defilipp
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417011037